NASDAQ:HCAT

Health Catalyst Competitors

$51.20
-0.08 (-0.16 %)
(As of 04/20/2021 03:59 PM ET)
Add
Compare
Today's Range
$50.49
Now: $51.20
$52.12
50-Day Range
$46.00
MA: $48.07
$51.85
52-Week Range
$24.22
Now: $51.20
$55.07
Volume49,214 shs
Average Volume440,894 shs
Market Capitalization$2.25 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.62

Competitors

Health Catalyst (NASDAQ:HCAT) Vs. TRIP, OCFT, DADA, CD, RXT, and SABR

Should you be buying HCAT stock or one of its competitors? Companies in the industry of "computer programming, data processing, & other computer related" are considered alternatives and competitors to Health Catalyst, including TripAdvisor (TRIP), OneConnect Financial Technology (OCFT), Dada Nexus (DADA), Chindata Group (CD), Rackspace Technology (RXT), and Sabre (SABR).

TripAdvisor (NASDAQ:TRIP) and Health Catalyst (NASDAQ:HCAT) are both mid-cap retail/wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

Analyst Ratings

This is a breakdown of recent ratings and target prices for TripAdvisor and Health Catalyst, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
TripAdvisor110602.29
Health Catalyst001013.09

TripAdvisor presently has a consensus target price of $38.1579, indicating a potential downside of 18.66%. Health Catalyst has a consensus target price of $45.1429, indicating a potential downside of 10.86%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than TripAdvisor.

Insider and Institutional Ownership

69.5% of TripAdvisor shares are owned by institutional investors. Comparatively, 94.2% of Health Catalyst shares are owned by institutional investors. 3.5% of TripAdvisor shares are owned by insiders. Comparatively, 22.1% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

TripAdvisor has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500.

Earnings and Valuation

This table compares TripAdvisor and Health Catalyst's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TripAdvisor$1.56 billion4.10$126 million$1.0843.96
Health Catalyst$154.94 million14.55$-60,100,000.00($1.42)-36.06

TripAdvisor has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than TripAdvisor, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares TripAdvisor and Health Catalyst's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
TripAdvisor-24.54%-15.76%-7.30%
Health Catalyst-48.17%-25.57%-14.56%

Summary

Health Catalyst beats TripAdvisor on 8 of the 15 factors compared between the two stocks.

OneConnect Financial Technology (NYSE:OCFT) and Health Catalyst (NASDAQ:HCAT) are both mid-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Insider and Institutional Ownership

14.4% of OneConnect Financial Technology shares are owned by institutional investors. Comparatively, 94.2% of Health Catalyst shares are owned by institutional investors. 22.1% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations and price targets for OneConnect Financial Technology and Health Catalyst, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OneConnect Financial Technology01402.80
Health Catalyst001013.09

OneConnect Financial Technology presently has a consensus price target of $26.80, suggesting a potential upside of 81.82%. Health Catalyst has a consensus price target of $45.1429, suggesting a potential downside of 10.86%. Given OneConnect Financial Technology's higher possible upside, analysts clearly believe OneConnect Financial Technology is more favorable than Health Catalyst.

Valuation & Earnings

This table compares OneConnect Financial Technology and Health Catalyst's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OneConnect Financial Technology$330.51 million17.23$-240,280,000.00($0.75)-19.47
Health Catalyst$154.94 million14.55$-60,100,000.00($1.42)-36.06

Health Catalyst has lower revenue, but higher earnings than OneConnect Financial Technology. Health Catalyst is trading at a lower price-to-earnings ratio than OneConnect Financial Technology, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares OneConnect Financial Technology and Health Catalyst's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OneConnect Financial Technology-19.82%-12.38%-6.11%
Health Catalyst-48.17%-25.57%-14.56%

Dada Nexus (NASDAQ:DADA) and Health Catalyst (NASDAQ:HCAT) are both mid-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings for Dada Nexus and Health Catalyst, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Dada Nexus01502.83
Health Catalyst001013.09

Dada Nexus presently has a consensus target price of $41.00, suggesting a potential upside of 82.87%. Health Catalyst has a consensus target price of $45.1429, suggesting a potential downside of 10.86%. Given Dada Nexus' higher probable upside, equities analysts clearly believe Dada Nexus is more favorable than Health Catalyst.

Earnings and Valuation

This table compares Dada Nexus and Health Catalyst's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dada Nexus$437.76 million12.11$-235,820,000.00($3.84)-5.85
Health Catalyst$154.94 million14.55$-60,100,000.00($1.42)-36.06

Health Catalyst has lower revenue, but higher earnings than Dada Nexus. Health Catalyst is trading at a lower price-to-earnings ratio than Dada Nexus, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Dada Nexus and Health Catalyst's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Dada NexusN/AN/AN/A
Health Catalyst-48.17%-25.57%-14.56%

Institutional & Insider Ownership

15.3% of Dada Nexus shares are held by institutional investors. Comparatively, 94.2% of Health Catalyst shares are held by institutional investors. 22.1% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Health Catalyst beats Dada Nexus on 8 of the 14 factors compared between the two stocks.

Chindata Group (NASDAQ:CD) and Health Catalyst (NASDAQ:HCAT) are both mid-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability.

Earnings and Valuation

This table compares Chindata Group and Health Catalyst's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chindata Group$120.74 million42.25$-24,690,000.00N/AN/A
Health Catalyst$154.94 million14.55$-60,100,000.00($1.42)-36.06

Chindata Group has higher earnings, but lower revenue than Health Catalyst.

Profitability

This table compares Chindata Group and Health Catalyst's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Chindata GroupN/AN/AN/A
Health Catalyst-48.17%-25.57%-14.56%

Analyst Ratings

This is a summary of recent ratings and recommmendations for Chindata Group and Health Catalyst, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Chindata Group01702.88
Health Catalyst001013.09

Chindata Group presently has a consensus target price of $20.91, indicating a potential upside of 49.04%. Health Catalyst has a consensus target price of $45.1429, indicating a potential downside of 10.86%. Given Chindata Group's higher possible upside, research analysts plainly believe Chindata Group is more favorable than Health Catalyst.

Institutional and Insider Ownership

18.9% of Chindata Group shares are owned by institutional investors. Comparatively, 94.2% of Health Catalyst shares are owned by institutional investors. 22.1% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Rackspace Technology (NASDAQ:RXT) and Health Catalyst (NASDAQ:HCAT) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.

Profitability

This table compares Rackspace Technology and Health Catalyst's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Rackspace TechnologyN/AN/AN/A
Health Catalyst-48.17%-25.57%-14.56%

Valuation and Earnings

This table compares Rackspace Technology and Health Catalyst's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rackspace TechnologyN/AN/AN/AN/AN/A
Health Catalyst$154.94 million14.55$-60,100,000.00($1.42)-36.06

Rackspace Technology has higher earnings, but lower revenue than Health Catalyst.

Insider and Institutional Ownership

78.3% of Rackspace Technology shares are held by institutional investors. Comparatively, 94.2% of Health Catalyst shares are held by institutional investors. 22.1% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Rackspace Technology and Health Catalyst, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Rackspace Technology001203.00
Health Catalyst001013.09

Rackspace Technology presently has a consensus price target of $27.9545, indicating a potential upside of 11.82%. Health Catalyst has a consensus price target of $45.1429, indicating a potential downside of 10.86%. Given Rackspace Technology's higher probable upside, analysts clearly believe Rackspace Technology is more favorable than Health Catalyst.

Health Catalyst (NASDAQ:HCAT) and Sabre (NASDAQ:SABR) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Health Catalyst and Sabre, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Health Catalyst001013.09
Sabre04202.33

Health Catalyst presently has a consensus target price of $45.1429, suggesting a potential downside of 10.86%. Sabre has a consensus target price of $13.60, suggesting a potential downside of 5.42%. Given Sabre's higher possible upside, analysts clearly believe Sabre is more favorable than Health Catalyst.

Insider and Institutional Ownership

94.2% of Health Catalyst shares are owned by institutional investors. Comparatively, 96.2% of Sabre shares are owned by institutional investors. 22.1% of Health Catalyst shares are owned by insiders. Comparatively, 0.7% of Sabre shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Health Catalyst and Sabre's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Health Catalyst-48.17%-25.57%-14.56%
Sabre-48.78%-105.75%-11.47%

Risk and Volatility

Health Catalyst has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Sabre has a beta of 2.18, indicating that its stock price is 118% more volatile than the S&P 500.

Earnings and Valuation

This table compares Health Catalyst and Sabre's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$154.94 million14.55$-60,100,000.00($1.42)-36.06
Sabre$3.97 billion1.15$158.59 million$0.8317.35

Sabre has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Sabre, indicating that it is currently the more affordable of the two stocks.

Summary

Sabre beats Health Catalyst on 8 of the 15 factors compared between the two stocks.


Health Catalyst Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
TripAdvisor logo
TRIP
TripAdvisor
1.3$47.48-11.6%$7.15 billion$1.56 billion-31.44
OCFT
OneConnect Financial Technology
1.4$14.60-7.4%$6.12 billion$330.51 million-60.83Decrease in Short Interest
Dada Nexus logo
DADA
Dada Nexus
1.3$22.48-4.1%$5.52 billion$437.76 million-5.85
Chindata Group logo
CD
Chindata Group
1.6$14.20-3.2%$5.26 billion$120.74 million0.00Increase in Short Interest
News Coverage
Rackspace Technology logo
RXT
Rackspace Technology
2.0$24.99-1.4%$5.22 billionN/A0.00Analyst Report
Increase in Short Interest
Sabre logo
SABR
Sabre
1.2$14.40-6.9%$4.88 billion$3.97 billion-4.21
Medallia logo
MDLA
Medallia
1.6$28.30-1.8%$4.52 billion$402.46 million-29.48
Switch logo
SWCH
Switch
1.5$18.01-1.1%$4.30 billion$462.31 million138.55Insider Selling
Magnite logo
MGNI
Magnite
1.7$35.13-2.6%$4.17 billion$156.41 million-57.59
HUYA logo
HUYA
HUYA
1.8$17.67-1.7%$3.92 billion$1.20 billion36.06
Cardlytics logo
CDLX
Cardlytics
1.1$118.05-2.8%$3.86 billion$210.43 million-70.27Analyst Upgrade
Insider Selling
21Vianet Group logo
VNET
21Vianet Group
1.2$27.38-2.0%$3.77 billion$544.25 million-9.64
Pluralsight logo
PS
Pluralsight
1.0$22.45-0.0%$3.33 billion$316.91 million-20.60
YALA
Yalla Group
1.2$22.57-2.5%$3.31 billionN/A0.00Increase in Short Interest
DouYu International logo
DOYU
DouYu International
1.5$10.02-2.3%$3.25 billion$1.04 billion27.83
SVMK logo
SVMK
SVMK
1.6$17.96-2.6%$2.66 billion$307.42 million-25.66News Coverage
Eventbrite logo
EB
Eventbrite
1.1$20.64-6.1%$2.04 billion$326.80 million-8.19
Model N logo
MODN
Model N
1.2$39.77-0.8%$1.41 billion$161.06 million-97.00
EverQuote logo
EVER
EverQuote
2.0$32.93-5.0%$984.38 million$248.81 million-106.22
GAN logo
GAN
GAN
1.1$16.94-4.1%$740.76 million$29.97 million0.00Increase in Short Interest
HealthStream logo
HSTM
HealthStream
1.2$22.14-1.8%$711.11 million$254.11 million42.58Upcoming Earnings
News Coverage
QTT
Qutoutiao
0.5$2.06-1.0%$630.24 million$790.85 million-2.48
Sify Technologies logo
SIFY
Sify Technologies
1.2$2.76-7.6%$532.29 million$326.31 million0.00
TrueCar logo
TRUE
TrueCar
1.4$4.17-7.0%$439.91 million$353.88 million-24.53
Aurora Mobile logo
JG
Aurora Mobile
0.5$3.21-2.2%$379.74 million$130.21 million-15.29
LIZI
Lizhi
1.5$6.15-4.6%$297.19 million$169.58 million-6.09Increase in Short Interest
Gap Up
ESSC
East Stone Acquisition
0.2$9.96-0.3%$176.85 millionN/A0.00Increase in Short Interest
News Coverage
Oblong logo
OBLG
Oblong
0.8$4.11-4.4%$114.19 million$12.83 million0.00
Alithya Group logo
ALYA
Alithya Group
0.6$2.12-3.3%$112.51 million$210.26 million-3.59
Synacor logo
SYNC
Synacor
0.7$2.19-0.0%$87.37 million$121.85 million-7.30
Moxian logo
MOXC
Moxian
0.3$5.30-12.3%$75.29 million$370,000.000.00Decrease in Short Interest
News Coverage
Gap Down
CNET
ZW Data Action Technologies
0.5$1.77-3.7%$57.29 million$58.08 million-10.38News Coverage
Gap Down
Jianpu Technology logo
JT
Jianpu Technology
1.0$2.67-4.1%$54.06 million$234.18 million-1.11Gap Up
Pintec Technology logo
PT
Pintec Technology
0.6$0.79-4.0%$35.32 million$184.61 million0.00Gap Down
AutoWeb logo
AUTO
AutoWeb
1.5$2.38-3.4%$32.40 million$113.98 million-3.50
GIGM
GigaMedia
0.6$2.87-1.4%$32.16 million$6.64 million-28.70
Professional Diversity Network logo
IPDN
Professional Diversity Network
0.4$1.58-4.4%$20.33 million$5.03 million0.00Gap Up
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.